Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein e knockout mice by the blood-pool contrast agent B22956/1

Molecular Imaging

Volumn 13, Issue 5, 2014, Pages

  Parolini, Cinzia ^a,b   Busnelli, Marco ^a,b   Ganzetti, Giulia S ^a,b   Dellera, Federica ^a,b   Manzini, Stefano ^a,b   Scanziani, Eugenio ^a,b   Johnson, Jason L ^a,b   Sirtori, Cesare R ^a,b   Chiesa, Giulia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; LAKES; LIPOPROTEINS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MUSCLE;

APOLIPOPROTEIN E; ATHEROSCLEROTIC LESIONS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR EVENT; CONTRAST AGENT; LINEAR CORRELATION; SIGNAL ENHANCEMENT; VULNERABLE PLAQUES;

MAMMALS;

APOLIPOPROTEIN E; B-22956-1; CONTRAST MEDIUM; ORGANOMETALLIC COMPOUND;

ANIMAL; BRACHIOCEPHALIC TRUNK; DIAGNOSTIC USE; GENETICS; KNOCKOUT MOUSE; LIPID DIET; MALE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; RADIOGRAPHY; SCINTISCANNING;

ANIMALS; APOLIPOPROTEINS E; BRACHIOCEPHALIC TRUNK; CONTRAST MEDIA; DIET, HIGH-FAT; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; ORGANOMETALLIC COMPOUNDS; PLAQUE, ATHEROSCLEROTIC;

EID: 84906068820     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2014.00012     Document Type: Article

References (32)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 2012;125:e2-220, doi:10.1161/CIR.0b013e31823ac046
2. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-8, doi:10.1016/j.jacc.2005.10.065
3. Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart 2004;90:1385-91, doi:10.1136/hrt.2004. 041798
4. Narula J, Garg P, Achenbach S, et al. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008;5 Suppl 2:S2-10, doi:10.1038/ncpcardio1247
5. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002;8:1257-62, doi:10.1038/nm1102-1257
6. Zadelaar S, Kleemann R, Verschuren L, et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007;27:1706-21, doi:10.1161/ATVBAHA.107.142570
7. Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40, doi:10.1161/ 01.ATV.14.1.133
8. Smith JD, Breslow JL. The emergence of mouse models of atherosclerosis and their relevance to clinical research. J Intern Med 1997;242:99-109, doi:10.1046/j.1365-2796.1997.00197.x
9. Rosenfeld ME, Polinsky P, Virmani R, et al. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000;20:2587-92, doi:10. 1161/01.ATV.20.12.2587
10. Jackson CL, Bennett MR, Biessen EA, et al. Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007;27: 714-20, doi:10.1161/01.ATV.0000261873.86623.e1
11. Bond AR, Jackson CL. The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture. J Biomed Biotechnol 2011;2011:379069
12. Choudhury RP, Fuster V, Badimon JJ, et al. MRI and characterization of atherosclerotic plaque: Emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol 2002;22: 1065-74, doi:10.1161/01.ATV.0000019735. 54479.2F
13. Corti R, Fuster V. Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J 2011;32:1709-19, doi:10.1093/eurheartj/ehr068
14. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112:3437-44, doi:10.1161/CIRCULATIONAHA.104.528174
15. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62-7, doi:10.1002/jmri.10030
16. Kerwin WS, O'Brien KD, Ferguson MS, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006;241:459-68, doi:10.1148/radiol.2412051336
17. Kerwin WS, Hatsukami T, Yuan C, et al. MRI of carotid atherosclerosis. AJR Am J Roentgenol 2013;200:W304-13, doi:10.2214/AJR.12.8665
18. de Haën C, Anelli PL, Lorusso V, et al. Gadocoletic acid trisodium salt (B22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. Invest Radiol 2006;41:279-91, doi:10.1097/01.rli.0000195848.17065.13
19. Cornily JC, Hyafil F, Calcagno C, et al. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging 2008;27:1406-11, doi:10.1002/jmri.21369
20. Johnson J, Carson K, Williams H, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse:model characterization and effects of pravastatin treatment. Circulation 2005;111:1422-30, doi:10.1161/01.CIR.0000158435.98035.8D
21. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013;368:2004-13, doi:10.1056/NEJMra1216063
22. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature 2008;451:953-7, doi:10.1038/nature06803
23. Briley-Saebo KC, Mulder WJ, Mani V, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 2007;26:460-79, doi:10.1002/jmri.20989
24. Anzidei M, Napoli A, Zaccagna F, et al. Diagnostic accuracy of colour Doppler ultrasonography, CT angiography and blood-poolenhanced MR angiography in assessing carotid stenosis: a comparative study with DSA in 170 patients Radiol Med 2012; 117:54-71, doi:10.1007/s11547-011-0651-3
25. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov 2011;10:835-52, doi:10.1038/nrd3578
26. Calcagno C, Ramachandran S, Millon A, et al. Gadolinium-Based Contrast Agents For Vessel Wall Magnetic Resonance Imaging (MRI) of atherosclerosis. Curr Cardiovasc Imaging Rep 2013;6:11-24, doi:10.1007/s12410-012-9177-x
27. Kanwar RK, Chaudhary R, Tsuzuki T, Kanwar JR. Emerging engineered magnetic nanoparticulate probes for targeted MRI of atherosclerotic plaque macrophages. Nanomedicine 2012;7:735-49, doi:10.2217/nnm.12.46
28. Majmudar MD, Yoo J, Keliher EJ, et al. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res 2013;122:755-61, doi:10.1161/CIRCRESAHA. 111.300576
29. Lipinski MJ, Amirbekian V, Frias JC, et al. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 2006; 56:601-10, doi:10.1002/mrm.20995
30. Phinikaridou A, Andia ME, Protti A, et al. Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation 2012;126:707-19, doi:10.1161/CIRCULATIONAHA.112.092098
31. Murphy CL, Lever MJ. Sulphorhodamine-B-labelled albumin uptake around the ostium of the renal artery in rabbits: changes with age. J Vasc Res 2002;39:104-13, doi:10.1159/000057759
32. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011;105 Suppl 1:S34- 42, doi:10.1160/THS10-11- 0717